11:45am ET
Investing
Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie & Fitch, Pfizer and Teva Pharmaceutical.
PFE Coverage Page 28
8:59am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm, ViacomCBS and More
Thursday's top analyst upgrades and downgrades included Apple, Best Buy, Electronic Arts, FireEye, Match, PayPal, Qualcomm and ViacomCBS.
8:35am ET
Investing
5 Very Safe High-Dividend Stocks to Buy Now for Worried Investors
These five outstanding stocks are rated Buy, have a least a 4% dividend and offer investors a degree of relative safety. They make sense for growth and income investors while the stock…
10:00am ET
Investing
Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
10:59am ET
Health and Healthcare
Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Chris Lange 8:59am ET
Investing
Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Exxon, GE, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto, Pfizer, Twitter and More
Wednesday's top analyst upgrades and downgrades included Chipotle Mexican Grill, Etsy, Exxon Mobil, General Electric, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto Networks, Pfizer and Twitter.
11:21am ET
Health and Healthcare
Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
9:50am ET
Health and Healthcare
5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
11:55am ET
Health and Healthcare
COVID-19 Vaccines Are on the Way and Major Players Are Cashing In
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
11:18am ET
Health and Healthcare
With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
10:56am ET
Health and Healthcare
Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial
Shares of COVID-19 vaccine duo Pfizer and BioNTech made handy gains on Wednesday after they announced their late-stage coronavirus study had concluded.
6:49am ET
Investing
Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
9:39am ET
Health and Healthcare
Moderna’s COVID-19 Vaccine Results Lift Blue Chips
Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90% efficacy in the past week.
8:59am ET
Economy
Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
9:45am ET
Health and Healthcare
Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market
Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.